Skip to content
2000
  1. Home
  2. A-Z Publications
  3. Applied Drug Research, Clinical Trials and Regulatory Affairs
  4. Volume 10, Issue 1
  5. Article
Volume 10, Issue 1
  • ISSN: 2667-3371
  • E-ISSN: 2667-338X

Abstract

Treatment of complicated fatal diseases was difficult when nanotechnology was not more popular. The incorporation of nanomedicine has increased in the last 13 years, even though regulatory guidelines regarding nanomaterials and nanomedicine weren't sufficient. Hence, it was tough to decide valid inevitability for the manufacturers, administrators, health professionals, primary care providers, and rest of the public that could ultimately have a negative impact on the financing system, research, and development of such items, affecting the approval of the public and acceptance of nano-products. This review includes coverage across the therapeutic value of nanomaterials, problems in the regulation, regulatory challenges, synthesis, physicochemical properties, and clinical application. The hurdles to using nanotechnology, particularly in the pharmaceutical development of novel medicinal products and respective regulatory issues, are critically explored, considering the characteristics offered by the nanomaterials.

© 2024 Bentham Science Publishers
Loading

Article metrics loading...

/content/journals/adctra/10.2174/0126673371276087240129102832
2024-03-05
2024-11-22

  • From This Site

    /content/journals/adctra/10.2174/0126673371276087240129102832
    dcterms_title,dcterms_subject,pub_keyword
    -contentType:Contributor -contentType:Concept -contentType:Institution
    10
    5
Loading full text...

Full text loading...

References

  1. GuptaA. PatelV.K. KantR. BhattacharyaS. Surface modification strategies for fabrication of nano-biodevices: A critical review.Rev Adhesion Adhesives20164216619110.7569/RAA.2016.097307
     [Google Scholar]
  2. AlamN. SiddiqueW. MishraM.K. PandeyA. PurshottamD.K. SinghK.J. TewariS.K. ChakrabartyD. Micropropagation of Hoya carnosa, H. kerrii, H. parasitica, and H. longifolia using tray-based floating and stationary hydroponic systems.Sci. Hortic. (Amsterdam)202331111180410.1016/j.scienta.2022.111804
     [Google Scholar]
  3. HaleemA. JavaidM. SinghR.P. RabS. SumanR. Applications of nanotechnology in medical field: A brief review.Global Health J202372707710.1016/j.glohj.2023.02.008
     [Google Scholar]
  4. ZhangY. DouY. LiuY. DiM. BianH. SunX. YangQ. Advances in therapeutic applications of extracellular vesicles.Int. J. Nanomedicine2023183285330710.2147/IJN.S40958837346366
     [Google Scholar]
  5. PrasadS. Nanobiosensors: The future for diagnosis of disease?Nanobiosensors Dis Diag2014311010.2147/NDD.S39421
     [Google Scholar]
  6. BoulaizH. AlvarezP.J. RamirezA. Nanomedicine: Application areas and development prospects.Int. J. Mol. Sci.20111253303332110.3390/ijms1205330321686186
     [Google Scholar]
  7. AbdihajiM. Mirzaei ChegeniM. HadizadehA. Polyvinyl Alcohol (PVA)-based nanoniosome for enhanced in vitro delivery and anticancer activity of thymol.Int. J. Nanomedicine2023183459348810.2147/IJN.S40172537396433
     [Google Scholar]
  8. AdabiM. NaghibzadehM. AdabiM. Biocompatibility and nanostructured materials: Applications in nanomedicine.Artif. Cells Nanomed. Biotechnol.201745483384210.1080/21691401.2016.117813427247194
     [Google Scholar]
  9. BleekerE.A.J. de JongW.H. GeertsmaR.E. Considerations on the EU definition of a nanomaterial: Science to support policy making.Regul. Toxicol. Pharmacol.201365111912510.1016/j.yrtph.2012.11.00723200793
     [Google Scholar]
  10. SarikayaM. TamerlerC. JenA.K.Y. SchultenK. BaneyxF. Molecular biomimetics: Nanotechnology through biology.Nat. Mater.20032957758510.1038/nmat96412951599
     [Google Scholar]
  11. UddinI. VenkatachalamS. MukhopadhyayA. Amil UsmaniM. Nanomaterials in the pharmaceuticals: Occurrence, behaviour and applications.Curr. Pharm. Des.201622111472148410.2174/138161282266616011810472726775674
     [Google Scholar]
  12. RenganathanS. VenkatesanH. PrabakaranK. DurairajM. AroulmojiV. Nanotechnology in materials and medical sciences.Int. J. Adv. Sci. Eng. Inf. Technol.20195310771084
     [Google Scholar]
  13. SinghA. PatelD.K. Nanomaterials for biomedical engineering applications.Nanomater Adv Technol.1st edSingaporeSpringer Nature20227510210.1007/978‑981‑19‑1384‑6_5
     [Google Scholar]
  14. AhnS. KangS.H. WooH. Liquid-metal core-shell particles coated with folate and phospholipids for targeted drug delivery and photothermal treatment of cancer cells.Nanomaterials (Basel)20231313201710.3390/nano1313201737446533
     [Google Scholar]
  15. SmolkovaB. DusinskaM. GabelovaA. Nanomedicine and epigenome. Possible health risks.Food Chem. Toxicol.2017109Pt 178079610.1016/j.fct.2017.07.02028705729
     [Google Scholar]
  16. HalwaniA.A. Development of pharmaceutical nanomedicines: From the bench to the market.Pharmaceutics202214110610.3390/pharmaceutics1401010635057002
     [Google Scholar]
  17. HockS.C. YingY.M. WahC.L. A review of the current scientific and regulatory status of nanomedicines and the challenges ahead.PDA J. Pharm. Sci. Technol.201165217719521502077
     [Google Scholar]
  18. FoulkesR. ManE. ThindJ. YeungS. JoyA. HoskinsC. The regulation of nanomaterials and nanomedicines for clinical application: Current and future perspectives.Biomater. Sci.20208174653466410.1039/D0BM00558D32672255
     [Google Scholar]
  19. SindhwaniS. ChanW.C.W. Nanotechnology for modern medicine: Next step towards clinical translation.J. Intern. Med.2021290348649810.1111/joim.1325433480120
     [Google Scholar]
  20. YagubluV. KarimovaA. HajibabazadehJ. Overview of physicochemical properties of nanoparticles as drug carriers for targeted cancer therapy.J. Funct. Biomater.202213419610.3390/jfb1304019636278665
     [Google Scholar]
  21. WuM. GuoH. LiuL. LiuY. XieL. Size-dependent cellular uptake and localization profiles of silver nanoparticles.Int. J. Nanomedicine2019144247425910.2147/IJN.S20110731239678
     [Google Scholar]
  22. LongmireM. ChoykeP.L. KobayashiH. Clearance properties of nano-sized particles and molecules as imaging agents: Considerations and caveats.Nanomedicine (Lond.)20083570371710.2217/17435889.3.5.70318817471
     [Google Scholar]
  23. WangT. WangL. LiX. Size-dependent regulation of intracellular trafficking of polystyrene nanoparticle-based drug-delivery systems.ACS Appl. Mater. Interfaces2017922186191862510.1021/acsami.7b0538328497682
     [Google Scholar]
  24. AdjeiI.M. SharmaB. LabhasetwarV. Nanoparticles: Cellular uptake and cytotoxicity.Adv. Exp. Med. Biol.2014811739110.1007/978‑94‑017‑8739‑0_524683028
     [Google Scholar]
  25. ZeinR. SharroufW. SeltingK. Physical properties of nanoparticles that result in improved cancer targeting.J. Oncol.2020202011610.1155/2020/519478032765604
     [Google Scholar]
  26. HoshyarN. GrayS. HanH. BaoG. The effect of nanoparticle size on in vivo pharmacokinetics and cellular interaction.Nanomedicine (Lond.)201611667369210.2217/nnm.16.527003448
     [Google Scholar]
  27. YamashitaS. MiyashitaS. HirataT. Size uncertainty in individual nanoparticles measured by single particle inductively coupled plasma mass spectrometry.Nanomaterials (Basel)20231313195810.3390/nano1313195837446474
     [Google Scholar]
  28. AkbariB. TavandashtiM.P. ZandrahimiM. Particle size characterization of nanoparticles-A practicalapproach.Iran J Mater Sci Eng2011824856
     [Google Scholar]
  29. HussainR. Alican NoyanM. WoyessaG. An ultra-compact particle size analyser using a CMOS image sensor and machine learning.Light Sci. Appl.2020912110.1038/s41377‑020‑0255‑632128161
     [Google Scholar]
  30. YangL. ZhouZ. SongJ. ChenX. Anisotropic nanomaterials for shape-dependent physicochemical and biomedical applications.Chem. Soc. Rev.201948195140517610.1039/C9CS00011A31464313
     [Google Scholar]
  31. ForestV. LeclercL. HochepiedJ.F. TrouvéA. SarryG. PourchezJ. Impact of cerium oxide nanoparticles shape on their in vitrocellular toxicity.Toxicol. In Vitro20173813614110.1016/j.tiv.2016.09.02227693598
     [Google Scholar]
  32. LiY. KrögerM. LiuW.K. Shape effect in cellular uptake of PEGylated nanoparticles: Comparison between sphere, rod, cube and disk.Nanoscale2015740166311664610.1039/C5NR02970H26204104
     [Google Scholar]
  33. ToyR. PeirisP.M. GhaghadaK.B. KarathanasisE. Shaping cancer nanomedicine: The effect of particle shape on the in vivo journey of nanoparticles.Nanomedicine (Lond.)20149112113410.2217/nnm.13.19124354814
     [Google Scholar]
  34. AllenC. QiuT.A. PramanikS. BuchmanJ.T. KrauseM.O.P. MurphyC.J. Research highlights: Investigating the role of nanoparticle surface charge in nano–bio interactions.Environ. Sci. Nano20174474174610.1039/C7EN90014G
     [Google Scholar]
  35. MoonJ. JiangH. LeeE.C. Physical surface modification of carbon-nanotube/polydimethylsiloxane composite electrodes for high-sensitivity DNA detection.Nanomaterials (Basel)20211110266110.3390/nano1110266134685103
     [Google Scholar]
  36. FuZ. GuX. HuL. LiY. LiJ. Radiation induced surface modification of nanoparticles and their dispersion in the polymer matrix.Nanomaterials (Basel)20201011223710.3390/nano1011223733187251
     [Google Scholar]
  37. KishoreA. JohnM. RallsA.M. JoseS.A. KuruveriU.B. MenezesP.L. Ultrasonic nanocrystal surface modification: Processes, characterization, properties, and applications.Nanomaterials (Basel)2022129141510.3390/nano1209141535564124
     [Google Scholar]
  38. LuoG. DuL. WangY. WangK. Encyclopedia of Microfluidics and Nanofluidics.2nd edSingaporeSpringer201545346010.1007/978‑1‑4614‑5491‑5_243
     [Google Scholar]
  39. ChoiM. ChoiW.K. JungC.H. KimS.B. The surface modification and characterization of SiO2 nanoparticles for higher foam stability.Sci. Rep.20201011939910.1038/s41598‑020‑76464‑w33173140
     [Google Scholar]
  40. KimS. KimE. KimS. KimW. Surface modification of silica nanoparticles by UV-induced graft polymerization of methyl methacrylate.J. Colloid Interface Sci.20052921939810.1016/j.jcis.2005.09.04616226762
     [Google Scholar]
  41. LiuJ.L. BashirS. Eds. Advanced nanomaterials and their applications in renewable energy.2nd edTexasElsevier Science202261110
     [Google Scholar]
  42. YadavT.P. Mechanical Milling: Atop down approach for the synthesis of nanomaterials and nanocomposites.Nanosci Nanotechnol201223224810.5923/j.nn.20120203.01
     [Google Scholar]
  43. SubinT.S. VijayanV. KumarK.J.R. Updated regulatory considerations for nanomedicines.Pharm. Nanotechnol.20175318019128641516
     [Google Scholar]
  44. ParamasivamG. PalemV.V. SundaramT. SundaramV. KishoreS.C. BellucciS. Nanomaterials: Synthesis and applications in theranostics.Nanomaterials (Basel)20211112322810.3390/nano1112322834947577
     [Google Scholar]
  45. ShuklaR.K. BadiyeA. VajpayeeK. KapoorN. Genotoxic potential of nanoparticles: Structural and functional modifications in DNA.Front. Genet.20211272825010.3389/fgene.2021.72825034659351
     [Google Scholar]
  46. Di IanniE. MøllerP. VogelU.B. JacobsenN.R. Pro-inflammatory response and genotoxicity caused by clay and graphene nanomaterials in A549 and THP-1 cells.Mutat. Res. Genet. Toxicol. Environ. Mutagen.202187250340510.1016/j.mrgentox.2021.50340534798932
     [Google Scholar]
  47. MankeA. WangL. RojanasakulY. Mechanisms of nanoparticle-induced oxidative stress and toxicity.BioMed Res. Int.2013201311510.1155/2013/94291624027766
     [Google Scholar]
  48. YangC. MerlinD. Challenges to safe nanomedicine treatment.Nanomaterials (Basel)2023137117110.3390/nano1307117137049268
     [Google Scholar]
  49. HoldrenJ.P. SunsteinC.R. SiddiquiI.A. Principles for regulation and oversight of emerging technologies, U.S. Memorandum for the Heads of Executive Departments and Agencies.2011Available From: https://obamawhitehouse.archives.gov/sites/default/files/omb/inforeg/for-agencies/Principles-for-Regulation-and-Oversight-of-Emerging-Technologies-new.pdf
  50. BawaR. BarenholzY. OwenA. The challenge of regulating nanomedicine: Key issues.LondonRoyal Society of Chemistry2016290314
     [Google Scholar]
  51. GasparR. Regulatory issues surrounding nanomedicines: Setting the scene for the next generation of nanopharmaceuticals.Nanomedicine (Lond.)20072214314710.2217/17435889.2.2.14317716116
     [Google Scholar]
  52. SahaB. BalM. Application of nanomaterials in medicine: Drug delivery, diagnostics and therapeutics.Int Res J Nanosci Nanotechnol2020211743
     [Google Scholar]
  53. Maleki DizajS. MennatiA. JafariS. KhezriK. AdibkiaK. Antimicrobial activity of carbon-based nanoparticles.Adv. Pharm. Bull.201551192325789215
     [Google Scholar]
  54. NikaljeA.P. Nanotechnology and its applications in medicine.Med. Chem.2015528189
     [Google Scholar]
  55. ChippaS. SuvarnaV. Nanotechnology for detection of diseases caused by viruses-current overview.Int. J. Pharm. Pharm. Sci.20211341710.22159/ijpps.2021v13i4.40359
     [Google Scholar]
  56. CamposE.V.R. PereiraA.E.S. de OliveiraJ.L. How can nanotechnology help to combat COVID-19? Opportunities and urgent need.J. Nanobiotechnology202018112510.1186/s12951‑020‑00685‑432891146
     [Google Scholar]
  57. MuneerM. MughalS.S. PervezS. MushtaqM. ShabbirN. AslamA. Diagnosis and treatment of diseases by using metallic nanoparticles.Int J Glob Sci2020312735
     [Google Scholar]
  58. LanJ. Overview of application of nanomaterials in medical domain.Contrast Media Mol. Imaging202220221510.1155/2022/350738335601569
     [Google Scholar]
  59. TangL. ChengJ. Nonporous silica nanoparticles for nanomedicine application.Nano Today20138329031210.1016/j.nantod.2013.04.00723997809
     [Google Scholar]
  60. NasirzadehK. NazarianS. HayatS.M.G. Inorganic Nanomaterials: A brief overview of the applications and developments in sensing and drug delivery.J Appl Biotechnol Rep201632395402
     [Google Scholar]
  61. NiculescuV.C. Mesoporous silica nanoparticles for bio-applications.Front. Mater.202073610.3389/fmats.2020.00036
     [Google Scholar]
  62. RajaniC. BorisaP. KaranwadT. BoradeY. Cancer-targeted chemotherapy: Emerging role of the folate anchored dendrimer as drug delivery nanocarrier. Pharmaceutical Applications of Dendrimers.TexasElsevier202015119810.1016/B978‑0‑12‑814527‑2.00007‑X
     [Google Scholar]
  63. JyolsnaP. Overview on different organic nanomaterials in medical field.J Pharm Sci& Res2020127973977
     [Google Scholar]
/content/journals/adctra/10.2174/0126673371276087240129102832
Loading
Regulation of Nanomaterials and Nanomedicines for Clinical Application
Applied Drug Research, Clinical Trials and Regulatory Affairs 10, E050324227671 (2024); https://doi.org/10.2174/0126673371276087240129102832
/content/journals/adctra/10.2174/0126673371276087240129102832
/content/journals/adctra/10.2174/0126673371276087240129102832
Loading

Data & Media loading...


  • Article Type:     Review Article
Keyword(s): genes; heart disease; nanomedicine; nanoparticles; Nanoscale; nanotechnology; tumor

Most Cited Most Cited RSS feed

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test